MedTrace Logo

Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection

NCT06268704 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2025-11-06

No results posted yet for this study

Summary

This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.

Conditions

  • Sacroiliac Joint Dysfunction
  • Sacro-Iliac Spondylosis

Interventions

DRUG

Dexamethasone

This is a non-particulate steroid commonly used to treat SI joint pain.

DRUG

Methylprednisolone

This is a particulate steroid commonly used to treat SI joint pain.

DRUG

2% Lidocaine HCl Injection

Lidocaine is a local anesthetic used in SI joint injection procedures to numb the procedure site and helps to confirm SI joint dysfunction when injected with the steroid medication into the SI joint.

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Reza Ehsanian, MD, PhD · University of New Mexico Department of Anesthesiology and Critical Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-27
Primary Completion
2027-01-01
Completion
2027-05-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06268704 on ClinicalTrials.gov